NCT05955131

Brief Summary

The goal of this trial is to assess in healthy subjects between 60 and 70 years the effect of glycemic and glycoxidative postprandial responses and platelet aggregation after intake of bread supplemented with Chilean beans flour when compared with a non supplemented control. The main questions to answer are:

  • It is possible to decrease postprandial glycemic and glycoxidative responses by means of the intake of bread supplemented with Chilean beans flour when compared to the intake of a control bread non supplemented in healthy elderly persons?
  • How is affected the platelet aggregation process during postprandial state after intake of bread supplemented with Chilean beans flour, when compared to the intake of a control bread non supplemented in healthy elderly persons? Participants will:
  • Be characterized by means of: 1) evaluation of body composition, using anthropometric techniques, bioimpedance and 2) biochemical analyses: biochemical profile, lipid profile, serum ferritin, fasting glycemia, HbA1c and insulin.
  • Arrive at fast to the laboratory and eat randomly control bread, 30% Chilean beans supplemented bread or glucose. Venous blood samples will be taken from the cubital fossa of the dominant arm at: 0, 30, 60 and 120 min postprandial, only after intake of bread control and supplemented bread. In addition, capillary blood will be taken at 0, 15, 30, 60, 90 and 120 min postprandial after intake of glucose, bread control or supplemented bread.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 5, 2023

Completed
25 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2023

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

June 27, 2023

Completed
24 days until next milestone

First Posted

Study publicly available on registry

July 21, 2023

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
Last Updated

July 21, 2023

Status Verified

July 1, 2023

Enrollment Period

25 days

First QC Date

June 27, 2023

Last Update Submit

July 19, 2023

Conditions

Keywords

Oxidative stressGlycoxidationAdvanced glycation end productsAgingBreadAntioxidantsFiberPlatelet aggregation

Outcome Measures

Primary Outcomes (1)

  • Change in the postprandial levels of methylglyoxal in plasma

    Determiantion of the change in the levels of methylglyoxal in plasma by means of pre-column derivatization and posterior separation, detection and quantification by means of high performance liquid chromatography and detection by fluorescence

    0, 30, 60 and 120 min postprandial

Study Arms (3)

Control Bread

OTHER

Subjects will eat control bread, in an amount containing 50g of carbohydrates

Other: Nutritional acute postprandial intervention: Control bread

Bread Supplemented with Chilean Beans

EXPERIMENTAL

Subjects will eat bread supplemented with Chilean native beans at 30% w/w, in an amount containing 50g of carbohydrates

Other: Nutritional acute postprandial intervention: bread suppelmented with Chilean beans

Glucose control

OTHER

Subjects will drink glucose, in an amount containing 50g of carbohydrates

Other: Nutritional acute postprandial intervention: Control glucose

Interventions

Volunteers will arrive at fasting and blood samples (aprox. 5mL) will be obtained before (0 min) and after the intake (10 min of intake) an amount of control bread containing 50g of carbohydrates, venous blood samples for determination of insulin, methyglyoxal, 3-deoxyglucosone and platelet aggregation will be collected at 30, 60, 90 and 120 mn postprandial. In addition, capillary slood will be obtained at 0, 15, 30, 60, 90 and 120 postprandial for glycemia determination

Control Bread

Volunteers will arrive at fasting and blood samples (aprox. 5mL) will be obtained before (0 min) and after the intake (10 min of intake) an amount of supplemented bread containing 50g of carbohydrates, venous blood samples for determination of insulin, methyglyoxal, 3-deoxyglucosone and platelet aggregation will be collected at 30, 60, 90 and 120 mn postprandial. In addition, capillary slood will be obtained at 0, 15, 30, 60, 90 and 120 postprandial for glycemia determination.

Bread Supplemented with Chilean Beans

Volunteers will arrive at fasting and capillary blood samples will be obtained before (0 min) and after the intake an amount of control glucose containing 50g of this monosscharide (10 min of intake), capillary slood will be also obtained at 15, 30, 60, 90 and 120 postprandial for glycemia determination.

Glucose control

Eligibility Criteria

Age60 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Persons between 60-70 years old.
  • Persons autonomous.
  • Persons who are willing to participate in this study and who have agreed and signed the informed consent.

You may not qualify if:

  • Clinical diagnosis of diabetes
  • Persons with levels of glycosylated hemoglobin (HbA1c) lhigher than 6.5
  • Clinical diagnosis and uncontrolled chronic diseases.
  • Anemia, dtermined by ferritin levels less than 15 µg/ L.
  • Oropharyngeal disorders (self-reported).
  • Persons with gastric bypass surgery.
  • Celiac disease (self-reported).
  • Coagulation disorders (self-reported).
  • Use of medications that modify the glycemic response or lipid profile (acarbose, thiazolinediones, metformin, insulin, orlistat, among others).
  • Clinical diagnosis of Alzheimer's disease or sinile dementia.
  • People with pacemakers or metal subcutaneous implants.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Nutrition and Dietetics

Talca, 3460000, Chile

Location

Study Officials

  • Felipe Ávila, PhD

    School of Nutrition and Dietetics, Health Sciences Faculty, University of Talca

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Blood samples will be codified, and the keys will be saved by Felipe Ávila. The personal in charge of the blood analyses (quantification of methylglyoxal and 3-deoxyglucosone) will register their results using the codes and therefore will not know the type of sample analyzing or the volunteer that provided the sample.
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: This study involves an acute nutritional intervention with crossover design, in which each volunteer will eat one out of tree meals (control bread, supplemented bread or glucose), randomly, once by week. Blood samples will be taken at 0min and 30, 60 and 120 min postprandial. The volunteers will complete their participation after the intake of the three meals, hence, their participation in the study will finish after 3 weeks.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asociate Professor

Study Record Dates

First Submitted

June 27, 2023

First Posted

July 21, 2023

Study Start

May 5, 2023

Primary Completion

May 30, 2023

Study Completion

April 30, 2024

Last Updated

July 21, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

This was not authorized by the Institutional Ethics Comitee

Locations